Modern Chinese Medicine Group Co., Ltd.

1643

KYG6181B1068

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 09:08:07 09/05/2024 BST			5-day change	1st Jan Change
0.345 ^HKD	+6.15%		+7.81%	+1.47%

03-22	Modern Chinese Medicine Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
03-13	Modern Chinese Medicine Warns of Up to 48% Profit Slump	MT

Modern Chinese Medicine Group Co., Ltd. Do Not Recommend the Payment of Final Dividend for the Year Ended 31 December 2022

April 26, 2023 at 12:38 pm

Modern Chinese Medicine Group Co., Ltd. does not recommended the payment of final dividend for the year ended 31 December 2022 (2021: HKD 0.0167 per ordinary share).

Latest news about Modern Chinese Medicine Group Co., Ltd.

Modern Chinese Medicine Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-22	CI
Modern Chinese Medicine Warns of Up to 48% Profit Slump	03-13	MT
Modern Chinese Medicine Group Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023	03-12	CI
Modern Chinese Medicine Arm Awards 121 Million Engineering Contract	11-06	MT
Modern Chinese Medicine Group Co., Ltd. Announces Director Changes and Change in Composition of the Nomination Committee	11-03	CI
Modern Chinese Medicine Group Co., Ltd. Announces Management Changes	30/08/23	CI
Modern Chinese Medicine Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23	CI
Modern Chinese Medicine's Profit to Drop Up to 50% in H1; Shares Drop 5%	21/08/23	MT
Modern Chinese Medicine Group Co., Ltd. Provides Preliminary Unaudited Consolidated Group Earnings Guidance for the Six Months 30 June 2023	18/08/23	CI
Modern Chinese Medicine Group Co., Ltd. Announces Change of Principal Place of Business in Hong Kong	30/06/23	CI
Modern Chinese Medicine Group Co., Ltd. Announces Executive Changes	30/06/23	CI
Modern Chinese Medicine Group Co., Ltd. Do Not Recommend the Payment of Final Dividend for the Year Ended 31 December 2022	26/04/23	CI
Modern Chinese Medicine Group Co., Ltd. Announces Board Changes	13/04/23	CI
Modern Chinese Medicine Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23/03/23	CI
Bai Hua Cun Pharma Tech Unit Raises Capital by 90 Million Yuan	26/12/22	MT
Modern Chinese Medicine Posts Rise in H1 Net Profit	26/08/22	MT
Modern Chinese Medicine Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/08/22	CI
Modern Chinese Medicine Group Co., Ltd. Announces Change of Address of Principal Place of Business in Hong Kong, with Effect from August 15, 2022	29/07/22	CI
Modern Chinese Medicine Group Co., Ltd. Approves Final Dividend for the Year Ended 31 December 2021	23/05/22	CI
Modern Chinese Medicine's Per-Share Earnings Slip on Higher Expenses in 2021	25/03/22	MT
Modern Chinese Medicine Group Co., Ltd. Recommends Final Dividend for the Year Ended 31 December 2021, Payable on 13 June 2022	25/03/22	CI
Modern Chinese Medicine Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	24/03/22	CI
Certain Ordinary Shares of Modern Chinese Medicine Group Co., Ltd. are subject to a Lock-Up Agreement Ending on 14-JAN-2022.	13/01/22	CI
Modern Chinese Medicine Chairman Passes Away	27/12/21	MT
Modern Chinese Medicine Group Co., Ltd. Announces Demise of Xie Wei, Chairman of the Board and Executive Director	24/12/21	CI

Chart Modern Chinese Medicine Group Co., Ltd.

Duration

Period

Chart Modern Chinese Medicine Group Co., Ltd.

More charts

Modern Chinese Medicine Group Co Ltd is a China-based investment holding company that mainly produces Chinese patent medicines. The Company mainly provides over-the-counter (OTC) and prescribed medicine intended for use by the middle-aged and elderly people. The Company's main products are Vigour and Vitality Supplement Pill, Circulation Enhancement Pill, Cardiotonic Enhancement Capsule, Kidney Invigoration Pill, Heart Wellness Capsule, Menstrual Discomfort Relief Pill, Liver Detox Tablet, Additional Ingredient Huoxiang ZhengQi Pill and Fever-removing and Detoxremoving Pill. The Company is also engaged in the production of other traditional Chinese medicines designed to treat or relieve other conditions such as psychological, respiratory, and pediatric conditions. The Company mainly conducts business within the domestic market.

Sector

Pharmaceuticals

Calendar

21/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
MODERN CHINESE MEDICINE GROUP CO., LTD.	+1.47%	24.94M
ELI LILLY AND COMPANY	+32.36%	698B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.40%	358B
MERCK & CO., INC.	+19.46%	328B
ABBVIE INC.	+3.50%	283B
ASTRAZENECA PLC	+16.34%	238B
NOVARTIS AG	+6.68%	203B
ROCHE HOLDING AG	-9.08%	198B
AMGEN INC.	+8.62%	165B

Other Pharmaceuticals